Gamida Cell Announces the Date of Its First Quarter 2023 Financial Results and Webcast
11 Maggio 2023 - 11:20PM
Business Wire
Gamida Cell Ltd. (Nasdaq: GMDA), a cell therapy pioneer working
to turn cells into powerful therapeutics, today announced that the
company will host a conference call and live audio webcast on
Monday, May 15, 2023, at 4:30 p.m. ET to review its first quarter
2023 financial results and provide an update on the company.
To access the conference call, please register here and be
advised to do so at least 10 minutes prior to joining the call. A
live webcast of the conference call can be accessed in the
“Investors & Media” section of the Gamida Cell website at
www.gamida-cell.com. A replay of the webcast will be available
approximately two hours after the event, for approximately 30
days.
About Gamida Cell
Gamida Cell is a cell therapy pioneer working to turn cells into
powerful therapeutics. The company’s proprietary nicotinamide (NAM)
technology leverages the properties of NAM to enhance and expand
cells, creating allogeneic cell therapy products and candidates
that are potentially curative for patients with hematologic
malignancies. These include Omisirge®, an FDA-approved nicotinamide
modified allogeneic hematopoietic progenitor cell therapy, and
GDA-201, an intrinsic NK cell therapy candidate being investigated
for the treatment of hematologic malignancies.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20230511005948/en/
Investor and media contact: Dan Boyle Orangefiery
media@orangefiery.com 1-818-209-1692
Grafico Azioni Gamida Cell (NASDAQ:GMDA)
Storico
Da Mag 2024 a Giu 2024
Grafico Azioni Gamida Cell (NASDAQ:GMDA)
Storico
Da Giu 2023 a Giu 2024
